Fraunhofer Institute for Toxicology and Experimental Medicine

Respiratory infections

Fraunhofer ITEM research teams are facing up to the challenges in infection research. Dr. Sabine Wronski, manager of the Working Group on Infection and Immunology, talks about this in an interview.

more info

Excellent stage for excellent research!

Fraunhofer ITEM is a part of the nationwide campaign “Hannover – city of excellence”

more info

Cluster of Excellence for Immune-Mediated Diseases CIMD

By teaming up with Fraunhofer IME, Fraunhofer IZI and other partners, we aim to advance the translation of innovative ideas and identified targets into individualized therapies for immune-mediated diseases.

more info

New guidance for endocrine disruptors and biocides

We support our clients concerning the compilation of data for the evaluation of the endocrine potential of biocides.

more info

Gentle treatment for premature babies

Researchers at Fraunhofer ITEM are working on an intelligent inhalation system for babies with lung diseases.

more info

MDR – handicap for the innovation hotspot Germany

High-Performance Center Translational Biomedical Engineering is suggesting specific measures for a revision of the Medical Device Regulation.

more info

Chip-based cell analysis by chip cytometry

New technology at Fraunhofer ITEM enables sputum analysis by chip cytometry.

more info

Project EU-ToxRisk

Fraunhofer ITEM scientists will test new approach methodologies for animal-free toxicity testing and risk assessment.

more info

Fraunhofer ITEM: News

 

News / 29.5.2019

Fraunhofer ITEM highlights of the year 2018

Our Annual Report 2018 is now available. We hope you will enjoy reading it.

Press Release / 29.5.2019

German-Australian iCAIR project

Fraunhofer iCAIR is breaking new ground in the development of antiviral drugs.

Events / 15.5.2019

Bio International Convention 2019

The Fraunhofer booth at this year's Bio International Convention from June 3-6, 2019 will focus on respiratory infections and in particular the iCAIR project.

 

News / 28.5.2019

Models of Lung Disease 2020 - Save the date!

The 19th Fraunhofer Seminar “Models of Lung Disease” will take place from February 6 to 7, 2020.

News / 8.5.2019

EFSA training courses open for registration

The EFSA training courses no. 3, "Endocrine disruptors" and no. 4, "Principles of genotoxicity in scientific assessment" are now open for registration.

News / 5.6.2019

Founding of the German Society for Metabolome Research

Dr. Sven Schuchardt of Fraunhofer ITEM elected treasurer.

 

Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0

Events

20.11.2019

Training course: In-silico toxicology

This training course will introduce the participants to three different in-silico approaches for estimation of human health toxicological endpoints, namely QSAR models, read-across, and the TTC (threshold of toxicological concern) concept. The application of in-silico approaches in ecotoxicology will not be addressed in this course.
Read more

8.7.2019

Open Session »TBMED«

Aiming to support European medtech companies in the global competition, the EU has initiated the project TBMED – An Open-Innovation Test Bed for the Development of High-Risk Medical Devices. Together with 12 project partners from Spain, France, Ireland and Germany, Fraunhofer ITEM is actively participating in the development of a test bed for medical devices of risk classification IIb and higher.
Read more

22.6.2019

STP 2019

The 38th Annual Symposium of the Society of Toxicologic Pathology will take place in Raleigh, North Carolina (USA), from June 22 to 27, 2019. Scientists and professionals will present and discuss the latest developments, products, technology, and services in the field of toxicologic pathology.
Read more

3.6.2019

BIO International Convention 2019

The BIO International Convention, the world's largest biotechnology trade fair, will take place in Philadelphia, USA from June 3 – 6, 2019. The Fraunhofer Group for Life Sciences will present its research in the area of therapeutic development, medical engineering, healthy foods, environmental research, and biobased economy at the »German Pavillon«.
Read more

Our services and expertise

 

Drug Development

From drug candidate to proof of concept

 

Chemical Safety and Assessment

From risk analysis towards safe products

 

Translational Biomedical Engineering

From idea to safe medical device

 

Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM